These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24084476)

  • 21. DNA vaccines: a role for liposomes.
    Gregoriadis G
    Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-based vaccines: recent technical and clinical advances.
    Ulmer JB; Wahren B; Liu MA
    Trends Mol Med; 2006 May; 12(5):216-22. PubMed ID: 16621717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of macrophage colony-stimulating factor receptor DNA vaccine.
    Wang Y; Zheng GG; Wu KF; Li G; Rao Q
    Haematologica; 2001 Nov; 86(11):1219-20. PubMed ID: 11694409
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-dose DNA vaccination into the submandibular lymph nodes in ponies.
    Landolt GA; Hussey SB; Kreutzer K; Quintana A; Lunn DP
    Vet Rec; 2010 Aug; 167(8):302-3. PubMed ID: 20729518
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA vaccines against cancer.
    Stan R; Wolchok JD; Cohen AD
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):613-36. PubMed ID: 16762727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of biolistic DNA vaccination in experimental type I allergy.
    Raker V; Maxeiner J; Reske-Kunz AB; Sudowe S
    Methods Mol Biol; 2013; 940():357-70. PubMed ID: 23104354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
    Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB
    Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of dengue DNA vaccines.
    Danko JR; Beckett CG; Porter KR
    Vaccine; 2011 Sep; 29(42):7261-6. PubMed ID: 21777640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in mucosal delivery of pDNA vaccines.
    Barnes AG; Barnfield C; Brew R; Klavinskis LS
    Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Matsumoto M; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Hum Vaccin; 2011; 7 Suppl():60-7. PubMed ID: 21546794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.
    Vardas E; Stanescu I; Leinonen M; Ellefsen K; Pantaleo G; Valtavaara M; Ustav M; Reijonen K
    Vaccine; 2012 Jun; 30(27):4046-54. PubMed ID: 22549090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines onward and upward! 20 years and counting! Highlights of the DNA vaccines 2012 meeting.
    Ugen K; Weiner DB
    Hum Vaccin Immunother; 2013 Oct; 9(10):2038-40. PubMed ID: 24131943
    [No Abstract]   [Full Text] [Related]  

  • 34. DNA vaccines for the treatment of prostate cancer.
    Alam S; McNeel DG
    Expert Rev Vaccines; 2010 Jul; 9(7):731-45. PubMed ID: 20624047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the development of DNA vaccines against foot-and-mouth disease.
    Fowler VL; Barnett PV
    Expert Rev Vaccines; 2012 Apr; 11(4):481-93. PubMed ID: 22551033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy for TB.
    Doherty TM
    Immunotherapy; 2012 Jun; 4(6):629-47. PubMed ID: 22788130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
    Gudmundsdotter L; Wahren B; Haller BK; Boberg A; Edbäck U; Bernasconi D; Buttò S; Gaines H; Imami N; Gotch F; Lori F; Lisziewicz J; Sandström E; Hejdeman B
    Vaccine; 2011 Jul; 29(33):5558-66. PubMed ID: 21300092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current progress of DNA vaccine studies in humans.
    Lu S; Wang S; Grimes-Serrano JM
    Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live-attenuated Listeria-based immunotherapy.
    Rothman J; Paterson Y
    Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.